← Leaderboards
Jieqing Zhu
Versiti Wisconsin, Inc.
$8,802,240
Attributed
$8,802,240
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.9M · FY2015–25$2M$1.5M$1M$500K$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$8,802,240 · 5
By mechanism
R01$7,559,740 · 3
P01$825,000 · 1
R56$417,500 · 1
Top collaborators
No co-investigators on record.
Most similar at Versiti Wisconsin, Inc.
Same institution · by research overlap
- Debra Kay Newman$3,628,275
- Daniel Bougie$459,250
Others in their field
Top investigators on “Molecular”
- David Heimbrook · Leidos Biomedical Research, Inc.$871,088,761
- Leonard Freedman · Leidos Biomedical Research, Inc.$468,573,385
- Richard Webby · St. Jude Children'S Research Hospital$254,843,170
- Larry Arthur$238,531,074
- Gregory H Reaman · National Childhood Cancer Foundation$230,630,913
- Ralph Parchment · Leidos Biomedical Research, Inc.$193,231,914
Research focus
MolecularMediatingThrombosisStructureRegulationFamilyLigand BindingBlood PlateletsMalignant NeoplasmsBiochemicalSignal TransductionProteinsCell SurfaceMemberTherapeutic TargetEventInflammationBiologyNovel StrategiesExtracellularExtracellular DomainDesignIntegrinsHemostatic Function
Grant awards (19)
Structural Transition of Cellular Integrins and Applications Thereof$797,844
R01 · FY2025 · HL · contact PI
Non-conventional signaling by α5 integrin in blood and endothelial cells$718,854
R01 · FY2025 · HL · contact PI
Protein Production, Structural Biology, and Nucleic Acid Sequencing and Analysis$412,500
P01 · FY2025 · HL · contact PI
Non-conventional signaling by α5 integrin in blood and endothelial cells$718,854
R01 · FY2024 · HL · contact PI
Protein Production, Structural Biology, and Nucleic Acid Sequencing and Analysis$412,500
P01 · FY2024 · HL · contact PI
Structural Transition of Cellular Integrins and Applications Thereof$560,922
R01 · FY2023 · HL · contact PI
Structural Mechanisms Underlying the Activity Regulation of the Receptor-like Protein Tyrosine Phosphatase, CD148/PTPRJ$330,000
R01 · FY2023 · GM · contact PI
Structural Transition of Cellular Integrins and Applications Thereof$560,922
R01 · FY2022 · HL · contact PI
Structural Mechanisms Underlying the Activity Regulation of the Receptor-like Protein Tyrosine Phosphatase, CD148/PTPRJ$330,000
R01 · FY2022 · GM · contact PI
Structural Transition of Cellular Integrins and Applications Thereof$560,922
R01 · FY2021 · HL · contact PI
Structural Mechanisms Underlying the Activity Regulation of the Receptor-like Protein Tyrosine Phosphatase, CD148/PTPRJ$330,000
R01 · FY2021 · GM · contact PI
Structural Mechanisms Underlying the Activity Regulation of the Receptor-like Protein Tyrosine Phosphatase, CD148/PTPRJ$90,500
R01 · FY2021 · GM · contact PI
Structural Transition of Cellular Integrins and Applications Thereof$560,922
R01 · FY2020 · HL · contact PI
Structural Mechanisms Underlying the Activity Regulation of the Receptor-like Protein Tyrosine Phosphatase, CD148/PTPRJ$330,000
R01 · FY2020 · GM · contact PI
Structural Transition of Cellular Integrins and Applications Thereof$417,500
R01 · FY2019 · HL · contact PI
Structural Transition of Cellular Integrins and Applications Thereof$417,500
R01 · FY2018 · HL · contact PI
Structural Transition of Cellular Integrins and Applications Thereof$417,500
R01 · FY2017 · HL · contact PI
Structural Transition of Cellular Integrins and Applications Thereof$417,500
R01 · FY2016 · HL · contact PI
Conformational regulation in integrin bidirectional transmembrane signaling$417,500
R56 · FY2015 · HL · contact PI